KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Debt Ratio (2016 - 2020)

Neogenomics filings provide 11 years of Debt Ratio readings, the most recent being 0.13 for Q1 2020.

  • On a quarterly basis, Debt Ratio rose 440.94% to 0.13 in Q1 2020 year-over-year; TTM through Mar 2020 was 0.13, a 440.94% increase, with the full-year FY2019 number at 0.14, down 28.02% from a year prior.
  • Debt Ratio hit 0.13 in Q1 2020 for Neogenomics, down from 0.14 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.28 in Q2 2018 to a low of 0.01 in Q2 2019.
  • Median Debt Ratio over the past 5 years was 0.09 (2017), compared with a mean of 0.11.
  • Biggest five-year swings in Debt Ratio: crashed 97.47% in 2019 and later surged 440.94% in 2020.
  • Neogenomics' Debt Ratio stood at 0.08 in 2016, then grew by 8.28% to 0.08 in 2017, then surged by 131.05% to 0.19 in 2018, then decreased by 28.02% to 0.14 in 2019, then dropped by 4.33% to 0.13 in 2020.
  • The last three reported values for Debt Ratio were 0.13 (Q1 2020), 0.14 (Q4 2019), and 0.01 (Q3 2019) per Business Quant data.